Department of Primary Care and Public Health (Chang, Lee, Vamos, Soljak, Majeed, Millet) and Division of Diabetes, Endocrinology and Metabolism (Johnston), Department of Medicine, Imperial College, London, UK; Saw Swee Hock School of Public Health (Lee), National University of Singapore, Singapore; Diabetes Research Centre (Khunti), Leicester Diabetes Centre, University of Leicester, Leicester, UK
Department of Primary Care and Public Health (Chang, Lee, Vamos, Soljak, Majeed, Millet) and Division of Diabetes, Endocrinology and Metabolism (Johnston), Department of Medicine, Imperial College, London, UK; Saw Swee Hock School of Public Health (Lee), National University of Singapore, Singapore; Diabetes Research Centre (Khunti), Leicester Diabetes Centre, University of Leicester, Leicester, UK.
CMAJ. 2016 Jul 12;188(10):E228-E238. doi: 10.1503/cmaj.151201. Epub 2016 May 2.
The National Health Service Health Check program in England is the largest cardiovascular risk assessment and management program in the world. We assessed the effect of this program on modelled risk of cardiovascular disease, individual risk factors for cardiovascular disease, prescribing of relevant medications and diagnosis of vascular disease.
We obtained retrospective electronic medical records for a randomly selected sample of 138 788 patients aged 40-74 years registered with 462 English general practices participating in the Clinical Practice Research Datalink between 2009 and 2013. We used a quasi-experimental design of difference-indifferences matching analysis to compare changes in outcomes between Health Check attendees and nonattendees, with a median follow-up time of 2 years.
Overall, 21.4% of the eligible population attended a Health Check. After matching (n = 29 672 in each group), attendees had a significant absolute reduction in modelled risk for cardiovascular disease (-0.21%, 95% confidence interval [CI] -0.24% to -0.19%) and individual risk factors: systolic blood pressure (-2.51 mm Hg, 95% CI -2.77 to -2.25 mm Hg), diastolic blood pressure (-1.46 mm Hg, 95% CI -1.62 to -1.29 mm Hg), body mass index (-0.27, 95% CI -0.34 to -0.20) and total cholesterol (-0.15 mmol/L, 95% CI -0.18 to -0.13 mmol/L). Statins were prescribed for 39.9% of attendees who were at high risk for cardiovascular disease. The program resulted in significantly more diagnoses of selected vascular diseases among attendees, with the largest increases for hypertension (2.99%) and type 2 diabetes mellitus (1.31%).
The National Health Service Health Check program had statistically significant but clinically modest impacts on modelled risk for cardiovascular disease and individual risk factors, although diagnosis of vascular disease increased. Overall program performance was substantially below national and international targets, which highlights the need for careful planning, monitoring and evaluation of similar initiatives internationally.
英国国民保健署健康检查计划是世界上最大的心血管风险评估和管理计划。我们评估了该计划对心血管疾病模型风险、心血管疾病个体风险因素、相关药物的处方和血管疾病诊断的影响。
我们从参与临床实践研究数据链接的 462 家英国普通实践中随机抽取了 138788 名 40-74 岁患者的回顾性电子病历,这些患者在 2009 年至 2013 年间登记。我们使用差异差异匹配分析的准实验设计来比较健康检查参与者和非参与者的结果变化,中位随访时间为 2 年。
总体而言,符合条件的人群中有 21.4%参加了健康检查。匹配后(每组 n=29672),参与者的心血管疾病模型风险显著降低(-0.21%,95%置信区间[CI] -0.24%至-0.19%)和个体风险因素:收缩压(-2.51mmHg,95%CI -2.77 至-2.25mmHg)、舒张压(-1.46mmHg,95%CI -1.62 至-1.29mmHg)、体重指数(-0.27,95%CI -0.34 至-0.20)和总胆固醇(-0.15mmol/L,95%CI -0.18 至-0.13mmol/L)。有心血管疾病高风险的参与者中有 39.9%开了他汀类药物。该计划导致参加者中选定血管疾病的诊断明显增加,其中高血压(2.99%)和 2 型糖尿病(1.31%)的增幅最大。
国民保健署健康检查计划对心血管疾病模型风险和个体风险因素有统计学上显著但临床意义不大的影响,尽管血管疾病的诊断有所增加。总体计划的实施情况远低于国家和国际目标,这突显了在国际上对类似举措进行仔细规划、监测和评估的必要性。